3 All-American Stocks To Nix International Volatility

 Now is the time to ditch any stocks with heavy international exposure. Global economic weakness and a strong dollar is hampering the growth prospects of all companies that derive revenue abroad. Replace those stocks with these three domestic focused stocks that will rise with our burgeoning economy. China has put a dent in the worldwide […]

Read more

My Bet’s Still on Biotech — 11 Stocks On Sale Today

Uncertainty in the market has been slowly building throughout the year and finally culminated in last Monday’s ‘flash crash’ a week ago. But, there is one certainty in the market; if you’re looking for growth there is no better sector than biotech, and these are the top stocks in the sector. After more than six […]

Read more

4 Post-Selloff Bargain Stocks in Biotech

Investors are getting whipsawed as the market cannot overcome increasing concerns around China, slowing global growth, the continuing collapse of both energy and commodity prices as well as a corresponding decline in currencies and economies of commodity based countries like Brazil, Malaysia, Australia, Russia and Canada among others. The slide continued Monday as Shanghai had […]

Read more

The Only Safe Haven in a Bear Market

Every 50 cent drop in the price of crude oil seems to knock another 2% off share values. It hurts, but it is during market corrections and the deeper bear markets when dividend investors have an advantage over investors whose primary focus is capital gains. The 60% decline in the price of crude oil has […]

Read more

Sell This High Flying Stock Before It’s Too Late

This stock, which is a favorite of retail investors, has been on a tear of late jumping 72% year-to-date. But, the valuation is being stretched beyond any realistic foundations. Now is the time to sell this dangerous stock that may be in your portfolio.  Amazon (NASDAQ: AMZN) overtook Walmart (NYSE: WMT) as the most valuable retailer in […]

Read more

This Dividend Stock Is Too Good to Be True

With a recent April 2015 IPO, this new high-yield dividend stock is making an exciting entrance into the market. With a 10% yield and an enthusiastic management team with visions of high growth, is this stock too good to be true, or is it just blowing hot air? If you are an income investor, you […]

Read more

Top 6 Biotechs to Buy After the Recent Sell-off

If you have missed out on the unbelievable gains in the biotech sector from Bret Jensen’s picks, like 464% from Eagle Pharmaceuticals in six months, don’t worry as a myriad of buying opportunities in the biotech sector have presented themselves over the last week. Bret Jensen is recommending that now is the right time to start building […]

Read more

3 Refining Stocks About to Report Record Profits

If you live anywhere in the Midwest, you  are probably experiencing gasoline sticker shock. While the price of crude keeps dropping, drivers in middle America are not getting any benefit from lower gas prices due to lower crude oil prices. The problem stems from an outage at BP’s (NYSE:BP) large refinery just east of Chicago. […]

Read more

Avoid These Stocks in 2016

If anything, the prospects for global growth have started to lessen further in recent weeks. After miserable economic readings from China, extraordinary measures taken to halt a big stock decline, and a devaluation of the Chinese currency, no one should believe their economy is growing at the “official” level of seven percent. Europe also just […]

Read more

The 4 Strategies to Investing for the Coming Correction

Investors Alley’s own Bret Jensen was recently interviewed by Investor in the Family where he discussed his approach to investing including his four pillars of investment strategy for long term gains that outperform the market. Bret further shares his methodology for investing in the red hot biotech space and offers a few investment ideas in […]

Read more

Warren Buffett Wants to Buy These 3 Stocks

The Oracle of Omaha is famous for making large purchases in companies like IBM and Coca-Cola, but this isn’t where he made all of his biggest returns. The investments that made Buffett worth $72 billion are in smaller, lesser-known companies with higher potential for growth and protection from competition. Hands down, Warren Buffett is one […]

Read more

3 REITs Boosting Dividends in September

One of the primary, if not the top, benefit of dividend-focused investing is to own shares that regularly increase their dividend payments. That is because dividend increases lead to share price appreciation and increase investors’ total returns. Buy these three REITs now to profit from the coming dividend boosts. One of the primary, if not […]

Read more

Buy These 3 Homebuilders Surging Higher

Right now there is a major tide shifting in the market, and the sectors that used to offer the best returns are now value traps. Energy and commodities are dead and big multinationals are weighed down by the strong dollar. But one sector – homebuilders – offers tremendous growth opportunities in this market. It has […]

Read more